Become A Featured Company

MedMen Expanding Across the US Legal Cannabis Markets

Robin Lefferts

November 15th, 2018

Exclusive, News, Top News

The recent elections brought the total number of states allowing some form of legalized cannabis to 33, with Michigan expanding its medical program to full adult use legalization and both Utah and Missouri voting for regulated medical programs. The legal U.S. cannabis market is steadily growing, making it the largest legal cannabis market in the world, with plenty of headroom for additional growth.

MedMen Enterprises (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM66N) is expanding accordingly. Already one of the largest legal cannabis operations in the country, MedMen is in the process of closing its acquisition of PharmaCann. Upon closing this and other pending deals MedMen will unquestionably be the largest U.S. cannabis company, with 69 retail stores and 17 cultivation and production facilities spread across 12 key states. Those 12 states are home to over 50% of the nation’s population.

Where is MedMen?

Let’s start with California, the largest and most important cannabis market in the US. MedMen blankets the trend-setting greater Los Angeles area with seven stores. It’s where the company began, and its success there allowed it to branch out into other key markets. MedMen recently announced a definitive agreement to buy its second retail store in Northern California, and the license in San Jose allows the company to also engage in cultivation, manufacturing, and distribution. MedMen intends to use the new location as the hub for further expansion in Northern California.

In general, MedMen’s strategy is to secure prime locations in vital markets for its modern and inviting retail stores. Starting in LA, Hollywood, and Venice Beach, the company now boasts prime locations on 5th Avenue in Manhattan and two (with a third coming soon) around Las Vegas. In Arizona, the company is focused on key retail locations in Scottsdale and Tempe. Its entry into the Illinois medical market is in the trendy and growing Oak Park suburb on Chicago’s West Side. MedMen has secured prime retail locations in the prime Florida markets of Fort Lauderdale, Miami Beach, West Palm Beach, St. Petersburg, and Key West. Its license in the state, one of only 14 granted there to this point, allows MedMen to open 30 or more medical dispensaries there.

The pending PharmaCann acquisition will greatly expand MedMen’s reach upon closing. PharmaCann holds licenses for retail and cultivation in Pennsylvania, Massachusetts, Ohio, Virginia, and Michigan. It currently operates four dispensaries and two production facilities in Illinois, along with four dispensaries and one production facility in New York, one dispensary in Massachusetts, and one dispensary in Maryland.

The Michigan licenses are even more intriguing now following the recent elections in which the state voted to legalize cannabis for adult-use. Having an established medical presence there, with both retail and production licenses, could give MedMen a head start in penetrating the significant recreational market opportunity offered by the new legalization.

Overall, MedMen is building what may be the broadest brand presence of any company, public or private, in the United States. That really is the game right now. With the variations in state regulations and the persistence of the federal ban on cannabis, most companies have been focused in localized markets. MedMen certainly started that way in Southern California as it built its brand, but its aggressive expansion and acquisition strategy has quickly expanded the company’s reach across the country. Keep an eye out for more developments as MedMen continues to execute.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Robin Lefferts

Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading